Conjunctiva may be replaced by many other tissues, as reviewed by Collin (1975) . In 1955 Gerendas prepared a plastic-like film, Bioplast, from human or animal fibrin by compression moulding of fibrin and glycerol. It is currently marketed by Ethicon Ltd, Edinburgh, under the registered name Biethium. It is a translucent, yellowish-brown, flexible preparation lending itself readily to implantation (Gerendas, 1959) . Horvath et al. (1969) stated that by prior heat-treatment Bioplast loses its antigenic properties, and it causes neither fever nor an immune response. It readily covers the tissues and allows natural or spontaneous healing to occur unobstructed. Bioplast is not incorporated into the repair. By its use regenerative processes in the surrounding tissues are stimulated. Having fulfilled its task, Bioplast is absorbed by enzymatic cellular digestion (Bagdy et al., 1963; Capperauld et al., 1977) .
Successful Bioplast implantations have been carried out in various fields of surgery and for a variety of conditions: in neurosurgery (Afra (1960) used Bioplast as a dural substitute); coxitis tuberculosa (Kovacs and Gerendas (1961) as a cup prosthesis over the hip joint); liver buffers (Drobni and Doczy, 1962; Drobni, 1965 and 1969; Wood et al., 1976) ; osteomyelitis (Winter and Papp, 1964) ; surgery of the nasal septum (Gyeney, 1973) and the maxilla (Kovacs and Kerenyi, 1976) ; and in the management of stress incontinence of urine in women (Horn et al., 1975) .
In ophthalmic surgery Grosz et al. (1967 Grosz et al. ( , 1968 Grosz et al. ( , 1976 were the first to use Bioplast for indenting the sclera in retinal detachment operations. Later Tapaszt6 (1973 Tapaszt6 ( , 1975 The author thanks Ethicon Ltd, Edinburgh, for supplying the implant material, and Novex Company Ltd, Budapest, for its technical assistance.
